Rezibase launches UK and Ireland rollout at ARTP 2026

By AI, Created 5:07 PM UTC, May 18, 2026, /AGP/ – Rezibase is expanding its respiratory and sleep lab platform into the UK and Ireland and will demo the system at ARTP 2026 in Belfast on May 21-22. The launch brings a vendor-neutral, AI-powered reporting and accreditation tool aimed at reducing manual work for clinical physiology labs.

Why it matters: - Rezibase is targeting clinical physiology labs that need faster reporting, less manual data entry and easier accreditation workflows. - The UK and Ireland launch leans on Cardiobase’s long NHS software track record, which may matter to hospitals evaluating secure, enterprise-grade systems. - The platform is built to support respiratory and sleep labs across public and private settings.

What happened: - Rezibase announced its official launch into the United Kingdom and Ireland markets on May 14, 2026. - Cardiobase will showcase the platform at the Association for Respiratory Technology and Physiology 50th Anniversary Conference on May 21-22, 2026, at the ICC Belfast. - Rezibase was developed in Australia by respiratory and sleep scientists Peter Rochford and the late Jeff Pretto. - The platform is currently used at more than 35 sites, including major teaching hospitals and private laboratories.

The details: - Rezibase is a cloud-based software-as-a-service platform for clinical physiology labs. - The system is manufacturer-agnostic, so labs can import data from any machine type. - The platform is designed to eliminate double data entry and the clinical risk that can follow. - Its “Magic Import” function automatically extracts discrete data, including flow-volume loops, from device reports. - The AI-powered reporting suite includes medical dictation, smart phrase auto-completion and an automated report writer. - The report writer generates interpretations based on American Thoracic Society guidelines. - The platform’s Accreditation Module centralizes document management, staff training, non-conformance tracking, action plans, audits and quality control. - The quality control workflow is based on Westgard methods. - Rezibase also supports electronic ordering, waitlist management, reporting and billing. - The platform integrates with hospital Patient Administration Systems and Electronic Medical Record systems. - Cardiobase has provided clinical software solutions to the NHS for 35 years. - The combined team brings 37 years of experience delivering secure technology to healthcare.

Between the lines: - The launch is framed around interoperability, a persistent pain point in hospital software buying. - The accreditation module points to a second need beyond reporting: helping labs manage ISO 15189 compliance with less manual effort. - The positioning around AI is practical rather than flashy. The emphasis is on automating repetitive tasks inside regulated workflows. - Mark Johnson, CEO of Cardiobase, said Rezibase was built by scientists to solve daily frustrations in clinical physiology labs and that the UK and Ireland rollout combines an advanced respiratory and sleep solution with a long NHS record. - Johnson also said the accreditation module is designed to cut the time needed to set up an accreditation system and reduce tedious manual work.

What’s next: - Rezibase will give live demonstrations at the ARTP conference in Belfast. - The company will show the platform across the full patient lifecycle, from electronic ordering and waitlist management to reporting and billing. - The UK and Ireland rollout now sets up Rezibase for broader adoption if hospitals and labs respond to the platform’s integration and compliance features.

The bottom line: - Rezibase is using ARTP 2026 to make its case as a vendor-neutral, AI-enabled lab platform built for reporting, compliance and integration in respiratory and sleep medicine.